Peptide vaccines for hematological malignancies: a missed promise? : Immunotherapy for Hematological MalignanciesBOCCHIA, Monica; DEFINA, Marzia; APRILE, Lara et al.International journal of hematology. 2014, Vol 99, Num 2, pp 107-116, issn 0925-5710, 10 p.Article

Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapiesCHIANESE-BULLOCK, Kimberly A; LEWIS, Sarah T; SHERMAN, Nicholas E et al.Vaccine. 2009, Vol 27, Num 11, pp 1764-1770, issn 0264-410X, 7 p.Article

The Protective Immune Response against Infectious Bronchitis Virus Induced by Multi-Epitope Based Peptide VaccinesYANG, Tai; WANT, Hong-Ning; WHANG, Xue et al.Bioscience, biotechnology, and biochemistry. 2009, Vol 73, Num 7, pp 1500-1504, issn 0916-8451, 5 p.Article

Design and optimization of a multiplex anti-influenza peptide immunoassayDRUMMOND, James E; SHAW, Eric E; ANTONELLO, Joseph M et al.Journal of immunological methods. 2008, Vol 334, Num 1-2, pp 11-20, issn 0022-1759, 10 p.Article

Gene Expression Profiles in Peripheral Blood as a Biomarker in Cancer Patients Receiving Peptide VaccinationKOMATSU, Nobukazu; MATSUEDA, Satoko; MATSUOKA, Kei et al.Cancer. 2012, Vol 118, Num 12, pp 3208-3221, issn 0008-543X, 14 p.Article

A Peptide Derived From Hepatitis C Virus (HCV) Core Protein Inducing Cellular Responses in Patients With HCV With Various HLA Class IA AllelesYAMEI NIU; KOMATSU, Nobukazu; KOMOHARA, Yoshihiro et al.Journal of medical virology. 2009, Vol 81, Num 7, pp 1232-1240, issn 0146-6615, 9 p.Article

Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2DONG, Xiao-Nan; CHEN, Ying-Hua.Vaccine. 2006, Vol 24, Num 11, pp 1906-1913, issn 0264-410X, 8 p.Article

Recent advances in peptide-based subunit nanovaccinesSKWARCZYNSKI, Mariusz; TOTH, Istvan.Nanomedicine (London. Print). 2014, Vol 9, Num 17, pp 2657-2669, issn 1743-5889, 13 p.Article

A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaBAE, Jooeun; WEIHUA SONG; SMITH, Robert et al.British journal of haematology. 2012, Vol 157, Num 6, pp 687-701, issn 0007-1048, 15 p.Article

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trialMITTENDORF, Elizabeth A; STORRER, Catherine E; FOLEY, Rebecca J et al.Cancer. 2006, Vol 106, Num 11, pp 2309-2317, issn 0008-543X, 9 p.Article

Levels of circulating regulatory CD4⁺CD25⁺ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccineHUEMAN, Matthew T; STOJADINOVIC, Alexander; STORRER, Catherine E et al.Breast cancer research and treatment. 2006, Vol 98, Num 1, pp 17-29, issn 0167-6806, 13 p.Article

Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinomaKOMOHARA, Yoshihiro; HARADA, Mamoru; ARIMA, Yoshimi et al.International journal of oncology. 2006, Vol 29, Num 6, pp 1555-1560, issn 1019-6439, 6 p.Article

Old and new vaccine approachesARNON, Ruth; BEN-YEDIDIA, Tamar.International immunopharmacology. 2003, Vol 3, Num 8, pp 1195-1204, issn 1567-5769, 10 p.Article

Recognition of a Natural WT1 Epitope by a Modified WT1 Peptide-specific T-Cell ReceptorTAMANAKA, Taichi; OKA, Yoshihiro; AKATSUKA, Yoshiki et al.Anticancer research. 2012, Vol 32, Num 12, pp 5201-5209, issn 0250-7005, 9 p.Article

Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 casesYOSHIDA, Kazumi; NOGUCHI, Masanori; MINE, Takashi et al.Oncology reports. 2011, Vol 25, Num 1, pp 57-62, issn 1021-335X, 6 p.Article

Dexamethasone Did Not Suppress Immune Boosting by Personalized Peptide Vaccination for Advanced Prostate Cancer PatientsNAITO, Masayasu; ITOH, Kyogo; NOGUCHI, Masanori et al.The Prostate. 2008, Vol 68, Num 16, pp 1753-1762, issn 0270-4137, 10 p.Article

Antibodies directed at a conserved motif in loop 6 of outer membrane protein P2 of nontypeable Haemophilus influenzae recognize multiple strains in immunoassaysNEARY, John M; MURPHY, Timothy F.FEMS immunology and medical microbiology. 2006, Vol 46, Num 2, pp 251-261, issn 0928-8244, 11 p.Article

Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with stage IV melanomaTAGAWA, Scott T; CHEUNG, Eric; BANTA, Warren et al.Cancer. 2006, Vol 106, Num 6, pp 1353-1357, issn 0008-543X, 5 p.Article

Personalized peptide vaccination in patients with refractory non-small cell lung cancerYOSHIYAMA, Koichi; TERAZAKI, Yasuhiro; SASADA, Tetsuro et al.International journal of oncology. 2012, Vol 40, Num 5, pp 1499-1507, issn 1019-6439, 9 p.Article

Comparison of different classes of CpG-ODN in augmenting the generation of human epitope peptide-specific CTLsKATSUDA, Masahiro; IWAHASHI, Makoto; MATSUDA, Kenji et al.International journal of oncology. 2011, Vol 39, Num 5, pp 1295-1302, issn 1019-6439, 8 p.Article

Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disordersBAE, Jooeun; TAI, Yu-Tzu; ANDERSON, Kenneth C et al.British journal of haematology. 2011, Vol 155, Num 3, pp 349-361, issn 0007-1048, 13 p.Article

Induction of circulating tumor-reactive CD8⁺ T cells after vaccination of melanoma patients with the gp100_209-2M peptideMEIJER, Sybren L; DOLS, Annemieke; JENSEN, Shawn M et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 5, pp 533-543, issn 1524-9557, 11 p.Article

Phase 1/11 study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancerMASUZAWA, Toru; FUJIWARA, Yoshiyuki; TAKEDA, Kazuyoshi et al.International journal of oncology. 2012, Vol 41, Num 4, pp 1297-1304, issn 1019-6439, 8 p.Article

Treatment of Established Lesions Caused by High-risk Human Papilloma Virus Using a Synthetic VaccineMELIEF, Cornelis J. M.Journal of immunotherapy (1997). 2012, Vol 35, Num 3, pp 215-216, issn 1524-9557, 2 p.Article

A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatinMATSUMOTO, Kazumasa; NOGUCHI, Masanori; SATOH, Takefumi et al.BJU international (Papier). 2011, Vol 108, Num 6, pp 831-838, issn 1464-4096, 8 p.Article